High cortical spreading depression susceptibility and migraine-associated symptoms in Cav2.1 S218L mice
Annals of Neurology , Volume 67 - Issue 1 p. 85- 98
Objective: The CACNA1A gene encodes the pore-forming subunit of neuronal Cav2.1 Ca2+channels. In patients, the S218L CACNA1A mutation causes a dramatic hemiplegic migraine syndrome that is associated with ataxia, seizures, and severe, sometimes fatal, brain edema often triggered by only a mild head trauma. Methods: We introduced the S218L mutation into the mouse Cacna1a gene and studied the mechanisms for the S218L syndrome by analyzing the phenotypic, molecular, and electrophysiological consequences. Results: Cacna1aS218Lmice faithfully mimic the associated clinical features of the human S218L syndrome. S218L neurons exhibit a gene dosage-dependent negative shift in voltage dependence of Cav2.1 channel activation, resulting in enhanced neurotransmitter release at the neuromuscular junction. Cacna1aS218Lmice also display an exquisite sensitivity to cortical spreading depression (CSD), with a vastly reduced triggering threshold, an increased propagation velocity, and frequently multiple CSD events after a single stimulus. In contrast, mice bearing the R192Q CACNA1A mutation, which in humans causes a milder form of hemiplegic migraine, typically exhibit only a single CSD event after one triggering stimulus. Interpretation: The particularly low CSD threshold and the strong tendency to respond with multiple CSD events make the S218L cortex highly vulnerable to weak stimuli and may provide a mechanistic basis for the dramatic phenotype seen in S218L mice and patients. Thus, the S218L mouse model may prove a valuable tool to further elucidate mechanisms underlying migraine, seizures, ataxia, and trauma-triggered cerebral edema.
|Annals of Neurology|
|Organisation||Erasmus MC: University Medical Center Rotterdam|
Dichgans, M, Pizzorusso, T, Kaja, S, Terpolilli, N, Shapovalova, M, Hoebeek, F.E, … Ferrari, M.D. (2010). High cortical spreading depression susceptibility and migraine-associated symptoms in Cav2.1 S218L mice. Annals of Neurology, 67(1), 85–98. doi:10.1002/ana.21815